CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels
- PMID: 15269840
- DOI: 10.1160/TH04-02-0095
CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels
Abstract
Monocytes play a central role in the inflammatory disease atherosclerosis. CD14+CD16+ monocytes are considered proinflammatory monocytes, as they have an increased capacity to produce proinflammatory cytokines, such as TNF-alpha, and are elevated in various inflammatory diseases. We hypothesized that patients with coronary artery disease (CAD) have increased levels of CD14+CD16+ monocytes, and that CD14+CD16+ monocytes are associated with inflammation markers. We investigated CD14+CD16+ monocytes in 247 patients with CAD and 61 control subjects using flow cytometry. In addition serum concentrations of TNF-alpha, IL-6, and Hs-CRP were assessed. Patients with CAD had higher levels of CD14+CD16+ monocytes than controls (13.6% versus 11.4%; p<0.001). Logistic regression analysis including quartiles of CD14+CD16+ monocytes showed that CD14+CD16+ monocytes were associated with prevalence of CAD (OR 4.9, 95% CI 2.5-19.1, for subjects in the fourth quartile in comparison to subjects in the first quartile). The association between CD14+CD16+ monocytes and CAD remained independently significant after adjustment for most potential confounders (OR 5.0, 95% CI 1.2-20.0). Serum concentrations of TNF-alpha were elevated in subjects within the highest quartiles of CD14+CD16+ monocytes (p=0.018). Our study showed that increased numbers of CD14+CD16+ monocytes are associated with coronary atherosclerosis and TNF-alpha. In accordance, recent animal studies suggest a possibly important role of these monocytes in the development of atherosclerosis.
Similar articles
-
Increased proatherogenic monocyte-platelet cross-talk in monocyte subpopulations of patients with stable coronary artery disease.J Intern Med. 2014 Feb;275(2):144-54. doi: 10.1111/joim.12145. Epub 2013 Oct 30. J Intern Med. 2014. PMID: 24118494
-
Xuemaitong granules attenuate carotid atherosclerosis by decreasing the expression of CD14+CD16+ monocytes, IL-6, TNF-α, and hsCRP.Genet Mol Res. 2014 Sep 12;13(3):7519-27. doi: 10.4238/2014.September.12.19. Genet Mol Res. 2014. PMID: 25222252
-
Senescent CD14+CD16+ monocytes exhibit proinflammatory and proatherosclerotic activity.J Immunol. 2011 Feb 1;186(3):1809-15. doi: 10.4049/jimmunol.1001866. Epub 2010 Dec 29. J Immunol. 2011. PMID: 21191073
-
The CD14+ CD16+ blood monocytes: their role in infection and inflammation.J Leukoc Biol. 2007 Mar;81(3):584-92. doi: 10.1189/jlb.0806510. Epub 2006 Nov 29. J Leukoc Biol. 2007. PMID: 17135573 Review.
-
CD14++ monocytes, CD14+/CD16+ subset and soluble CD14 as biological markers of inflammatory systemic diseases and monitoring immunosuppressive therapy.Clin Chem Lab Med. 1999 Mar;37(3):209-13. doi: 10.1515/CCLM.1999.039. Clin Chem Lab Med. 1999. PMID: 10353463 Review.
Cited by
-
Functional role of monocytes and macrophages for the inflammatory response in acute liver injury.Front Physiol. 2012 Oct 19;3:56. doi: 10.3389/fphys.2012.00056. eCollection 2012. Front Physiol. 2012. PMID: 23091461 Free PMC article.
-
HIV-specific immune dysregulation and atherosclerosis.Curr HIV/AIDS Rep. 2012 Sep;9(3):200-5. doi: 10.1007/s11904-012-0123-y. Curr HIV/AIDS Rep. 2012. PMID: 22638983 Review.
-
Atherosclerosis and the role of immune cells.World J Clin Cases. 2015 Apr 16;3(4):345-52. doi: 10.12998/wjcc.v3.i4.345. World J Clin Cases. 2015. PMID: 25879006 Free PMC article. Review.
-
Anti-platelet drugs attenuate the expansion of circulating CD14highCD16+ monocytes under pro-inflammatory conditions.Cardiovasc Res. 2016 Jul 1;111(1):26-33. doi: 10.1093/cvr/cvw089. Epub 2016 Apr 26. Cardiovasc Res. 2016. PMID: 27118470 Free PMC article. Clinical Trial.
-
Coronary atherosclerosis severity is closely associated with decreased GLP-1R positivity among CD16+ pro-inflammatory and patrolling monocyte subsets.Atheroscler Plus. 2021 Oct 13;46:15-19. doi: 10.1016/j.athplu.2021.10.001. eCollection 2021 Dec. Atheroscler Plus. 2021. PMID: 36643724 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous